202 related articles for article (PubMed ID: 14568948)
21. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
Johnson LM; Scott P
J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
[TBL] [Abstract][Full Text] [Related]
22. Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis.
Schreiber T; Ehlers S; Aly S; Hölscher A; Hartmann S; Lipp M; Lowe JB; Hölscher C
J Immunol; 2006 Jan; 176(2):1131-40. PubMed ID: 16394002
[TBL] [Abstract][Full Text] [Related]
23. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.
Zaph C; Uzonna J; Beverley SM; Scott P
Nat Med; 2004 Oct; 10(10):1104-10. PubMed ID: 15448686
[TBL] [Abstract][Full Text] [Related]
24. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection.
Monteforte GM; Takeda K; Rodriguez-Sosa M; Akira S; David JR; Satoskar AR
J Immunol; 2000 Jun; 164(11):5890-3. PubMed ID: 10820270
[TBL] [Abstract][Full Text] [Related]
25. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
[TBL] [Abstract][Full Text] [Related]
26. The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo.
Alcaide P; King SL; Dimitroff CJ; Lim YC; Fuhlbrigge RC; Luscinskas FW
J Invest Dermatol; 2007 Aug; 127(8):1964-72. PubMed ID: 17392823
[TBL] [Abstract][Full Text] [Related]
27. Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII.
Piccio L; Rossi B; Colantonio L; Grenningloh R; Gho A; Ottoboni L; Homeister JW; Scarpini E; Martinello M; Laudanna C; D'Ambrosio D; Lowe JB; Constantin G
J Immunol; 2005 May; 174(9):5805-13. PubMed ID: 15843584
[TBL] [Abstract][Full Text] [Related]
28. Migration of activated CD8(+) T lymphocytes to sites of viral infection does not require endothelial selectins.
Bartholdy C; Marker O; Thomsen AR
Blood; 2000 Feb; 95(4):1362-9. PubMed ID: 10666212
[TBL] [Abstract][Full Text] [Related]
29. IL-12 is required to maintain a Th1 response during Leishmania major infection.
Park AY; Hondowicz BD; Scott P
J Immunol; 2000 Jul; 165(2):896-902. PubMed ID: 10878364
[TBL] [Abstract][Full Text] [Related]
30. Alpha(1,3)-fucosyltransferase VII and alpha(2,3)-sialyltransferase IV are up-regulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites.
Blander JM; Visintin I; Janeway CA; Medzhitov R
J Immunol; 1999 Oct; 163(7):3746-52. PubMed ID: 10490970
[TBL] [Abstract][Full Text] [Related]
31. CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin.
Matsumoto M; Shigeta A; Furukawa Y; Tanaka T; Miyasaka M; Hirata T
J Immunol; 2007 Feb; 178(4):2499-506. PubMed ID: 17277158
[TBL] [Abstract][Full Text] [Related]
32. Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heart.
Cai YH; Alvarez A; Alcaide P; Duramad P; Lim YC; Jarolim P; Lowe JB; Luscinskas FW; Lichtman AH
J Immunol; 2006 Jun; 176(11):6568-75. PubMed ID: 16709814
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
Mocci S; Coffman RL
J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
[TBL] [Abstract][Full Text] [Related]
34. IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance.
Lazarski CA; Ford J; Katzman SD; Rosenberg AF; Fowell DJ
PLoS One; 2013; 8(8):e71949. PubMed ID: 23991011
[TBL] [Abstract][Full Text] [Related]
35. IL-13 is a susceptibility factor for Leishmania major infection.
Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
[TBL] [Abstract][Full Text] [Related]
36. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
[TBL] [Abstract][Full Text] [Related]
38. Potent induction of alpha(1,3)-fucosyltransferase VII in activated CD4+ T cells by TGF-beta 1 through a p38 mitogen-activated protein kinase-dependent pathway.
Wagers AJ; Kansas GS
J Immunol; 2000 Nov; 165(9):5011-6. PubMed ID: 11046029
[TBL] [Abstract][Full Text] [Related]
39. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.
Anderson CF; Stumhofer JS; Hunter CA; Sacks D
J Immunol; 2009 Oct; 183(7):4619-27. PubMed ID: 19748991
[TBL] [Abstract][Full Text] [Related]
40. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
